VAR2Pharmaceuticals receives a 7 million DKK grant

VAR2Pharmaceuticals receives a 7 million DKK grant from the Danish Innovation Foundation for ”Targeting cancer using a malaria derived protein drug conjugate”.

Continue reading

Hope for a general cure for cancer

Copenhagen, Denmark, October 13, 2015:   Targeting carbohydrates provides a new Danish biotech company, VAR2 Pharmaceuticals, with an effective weapon against cancer. Today VAR2 Pharmaceuticals announced the publication of breakthrough data in the renowned scientific journal Cancer C......
Continue reading

Videnskupon

VAR2 Pharmaceuticals has received an extended Knowledge Voucher from Danish Council for Technology and Innovation. The Voucher will be used to establish a collaboration between researchers at University of Copenhagen and Bioneer with the aim at optimizing production methods and stability of our pro......
Continue reading